AU756423B2 - Scintillation proximity test - Google Patents

Scintillation proximity test Download PDF

Info

Publication number
AU756423B2
AU756423B2 AU87429/98A AU8742998A AU756423B2 AU 756423 B2 AU756423 B2 AU 756423B2 AU 87429/98 A AU87429/98 A AU 87429/98A AU 8742998 A AU8742998 A AU 8742998A AU 756423 B2 AU756423 B2 AU 756423B2
Authority
AU
Australia
Prior art keywords
phosphor
assay
beads
spa
wells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU87429/98A
Other languages
English (en)
Other versions
AU8742998A (en
Inventor
Robert A. Jessop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Amersham PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8229469&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU756423(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham PLC filed Critical Amersham PLC
Publication of AU8742998A publication Critical patent/AU8742998A/en
Assigned to AMERSHAM PLC reassignment AMERSHAM PLC Amend patent request/document other than specification (104) Assignors: NYCOMED AMERSHAM PLC
Application granted granted Critical
Publication of AU756423B2 publication Critical patent/AU756423B2/en
Assigned to GE HEALTHCARE LIMITED reassignment GE HEALTHCARE LIMITED Request to Amend Deed and Register Assignors: AMERSHAM PLC
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Stereophonic System (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Conversion Of X-Rays Into Visible Images (AREA)
  • Nuclear Medicine (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Luminescent Compositions (AREA)
AU87429/98A 1997-08-18 1998-08-17 Scintillation proximity test Expired AU756423B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97306264 1997-08-18
EP97306264 1997-08-18
PCT/GB1998/002459 WO1999009415A1 (en) 1997-08-18 1998-08-17 Scintillation proximity test

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2002302004A Division AU2002302004A1 (en) 1997-08-18 2002-11-13 Scintillation proximity test

Publications (2)

Publication Number Publication Date
AU8742998A AU8742998A (en) 1999-03-08
AU756423B2 true AU756423B2 (en) 2003-01-09

Family

ID=8229469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87429/98A Expired AU756423B2 (en) 1997-08-18 1998-08-17 Scintillation proximity test

Country Status (9)

Country Link
US (4) US6524786B1 (enExample)
EP (1) EP1007971B2 (enExample)
JP (1) JP3719932B2 (enExample)
AT (1) ATE274189T1 (enExample)
AU (1) AU756423B2 (enExample)
DE (1) DE69825758T3 (enExample)
DK (1) DK1007971T3 (enExample)
ES (1) ES2227869T3 (enExample)
WO (1) WO1999009415A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756423B2 (en) * 1997-08-18 2003-01-09 Ge Healthcare Limited Scintillation proximity test
GB2342350A (en) * 1998-10-05 2000-04-12 Univ Nottingham Trent Solid supports containing oxazole scintillants
JP4282251B2 (ja) 2000-08-02 2009-06-17 富士フイルム株式会社 生化学解析用ユニットおよびそれを用いた生化学解析方法
GB0027516D0 (en) * 2000-11-10 2000-12-27 Amersham Pharm Biotech Uk Ltd Support and method for cell based assays
GB0107563D0 (en) 2001-03-27 2001-05-16 Amersham Pharm Biotech Uk Ltd NO synthase assay particles and method
US7011814B2 (en) * 2001-04-23 2006-03-14 Sicel Technologies, Inc. Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject
KR100483314B1 (ko) * 2002-03-23 2005-04-15 학교법인 인제학원 디지털 엑스레이 이미지 디텍터
US7072628B2 (en) * 2002-04-05 2006-07-04 Qualcomm, Incorporated Method and apparatus for determining receive diversity in mobile station
US7454006B2 (en) * 2003-01-31 2008-11-18 Qwest Communications International Inc. Systems, methods and apparatus for providing a plurality of telecommunication services
GB0403913D0 (en) * 2004-02-21 2004-03-24 Amersham Biosciences Uk Ltd P-glycoprotein assay
CN1280623C (zh) * 2004-07-16 2006-10-18 北京博奥生物芯片有限责任公司 一种用于荧光仪器校准测量的校准基片及其制备方法
US20070037215A1 (en) * 2005-08-11 2007-02-15 Patton Wayne F Assay particles and methods of use
WO2007077291A1 (en) 2005-12-30 2007-07-12 Turun Yliopisto Method for determination of concentration, charge or unit size of a substance
DE102006031563A1 (de) * 2006-06-27 2008-01-03 Dieter Ebert Lumineszenzstoff-Zusammensetzung
WO2015126953A1 (en) * 2014-02-18 2015-08-27 Shire Human Genetic Therapies, Inc. Substrate clearance assays for lysosomal enzymes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415808A (en) * 1980-12-24 1983-11-15 General Electric Company Scintillation detector array employing zig-zag plates
GB8513538D0 (en) 1985-05-29 1985-07-03 Mackay C D Electrophoresis
JPS6247555A (ja) * 1985-08-23 1987-03-02 エフ．ホフマン　―　ラ　ロシュ　アーゲー シンチレ−シヨン近接定量法
US4922092A (en) * 1986-11-26 1990-05-01 Image Research Limited High sensitivity optical imaging apparatus
EP0502123A4 (en) * 1989-12-01 1992-11-04 Packard Instrument Company, Inc. Scintillation proximity radioimmunoassay using solid scintillator support body
EP0510753B1 (en) * 1991-04-26 1996-10-23 Agfa-Gevaert N.V. Luminescent article with protective coating and manufacture
ATE188724T1 (de) * 1992-02-14 2000-01-15 Nycomed Amersham Plc Fluoreszente verbundstoffe
EP0688849B1 (en) * 1992-02-14 2000-01-12 Nycomed Amersham plc Fluorescent compounds
JPH0627023A (ja) * 1992-07-07 1994-02-04 Toto Ltd 光バイオセンサー
US5698397A (en) * 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
FI925064A7 (fi) * 1992-11-09 1994-05-10 Erkki Juhani Soini Menetelmä ja laitteisto bioaffiniteettimäärityksiä varten
DE650396T1 (de) * 1993-05-17 1995-11-30 Amersham Int Plc Vorrichtung und verfahren zum nachweis zellularer und biochemischer prozesse.
JPH072955U (ja) * 1993-06-17 1995-01-17 アロカ株式会社 マイクロプレート
US6319530B1 (en) * 1993-07-07 2001-11-20 Jack Guttman, Inc. Method of photocopying an image onto an edible web for decorating iced baked goods
JPH07270426A (ja) * 1994-03-31 1995-10-20 Suzuki Motor Corp 血液等の凝集データ収集装置
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
EP0744451B1 (en) * 1995-05-25 1999-07-21 AMERSHAM INTERNATIONAL plc Fluorescent compounds
JP3518940B2 (ja) * 1996-01-09 2004-04-12 オリンパス株式会社 免疫反応検査装置の性能管理方法および免疫反応検査装置用性能管理プレート
AU756423B2 (en) * 1997-08-18 2003-01-09 Ge Healthcare Limited Scintillation proximity test
US6198577B1 (en) * 1998-03-10 2001-03-06 Glaxo Wellcome, Inc. Doubly telecentric lens and imaging system for multiwell plates
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BEVERLOO H B ET AL, (1992) CYTOMETRY 13 PP 561-570 *

Also Published As

Publication number Publication date
US20070207547A1 (en) 2007-09-06
JP3719932B2 (ja) 2005-11-24
ES2227869T3 (es) 2005-04-01
DK1007971T3 (da) 2004-12-06
EP1007971B1 (en) 2004-08-18
JP2001516028A (ja) 2001-09-25
WO1999009415A1 (en) 1999-02-25
US20060141536A1 (en) 2006-06-29
DE69825758T3 (de) 2011-01-13
US20030152978A1 (en) 2003-08-14
AU8742998A (en) 1999-03-08
US6524786B1 (en) 2003-02-25
DE69825758T2 (de) 2005-09-01
EP1007971B2 (en) 2009-07-22
ATE274189T1 (de) 2004-09-15
US7214539B2 (en) 2007-05-08
US7081365B2 (en) 2006-07-25
EP1007971A1 (en) 2000-06-14
DE69825758D1 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
US20070207547A1 (en) Scintillation proximity test
EP0154734B1 (en) Immediate ligand detection assay, a test kit and its formation
US4568649A (en) Immediate ligand detection assay
Sittampalam et al. High-throughput screening: advances in assay technologies
US5739042A (en) Method of assay
JPH03503081A (ja) 数種の被検物質の環境内濃度の定量
EP0736177B1 (en) Method of assay using two distinguishable types of particles
US6551788B1 (en) Particle-based ligand assay with extended dynamic range
Degorce HTRF®: Pioneering technology for high-throughput screening
Härmä et al. Multiplex immunoassays on size-categorized individual beads using time-resolved fluorescence
Jessop Imaging proximity assays
Seethala Homogeneous assays for high-throughput and ultrahigh-throughput screening
US7264921B2 (en) No synthase assay particles and method
Jones et al. Color quench correction in scintillation proximity assays using paralux count mode
CA2179826C (en) Method of assay
US20070128732A1 (en) Scintillator composition for a radioassay, and method for its use
FI91920B (fi) Menetelmä biospesifisen moniparametrisen määritysmenetelmän tarkkuuden parantamiseksi
Merk et al. Peptide protein binding assay using ImageFlashPlates or Imaging Beads
GB2366370A (en) Reagent for scintillation proximity assays
Upham et al. INTRODUCTION TO HOMOGENEOUS TIME-RESOLVED FLUORESCENCE
Juntunen et al. Performance of fluorescent Eu (III)-nanoparticles and colloidal gold reporters in lateral flow bioaffinity assay
Kolb¹ et al. Homogeneous, Time-Resolved
AU2002238744A1 (en) No synthase assay particles and method

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: AMERSHAM PLC

Free format text: FORMER NAME: NYCOMED AMERSHAM PLC

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired